Navigation Links
Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
Date:7/2/2012

CRANBURY, N.J., July 2, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) today announced that it has entered into a definitive securities agreement and priced a private placement of 3,873,000 shares of its common stock, Series A warrants to purchase 31,988,151 shares of its common stock, and Series B warrants to purchase 35,488,380 shares of its common stock.  Funds under the management of QVT Financial LP have agreed to pay $0.50 for each share of common stock and $0.49 for each Series A warrant and each Series B warrant, resulting in gross proceeds to Palatin of $35,000,000, with net proceeds, after deducting estimated offering expenses, of approximately $34,500,000.

The private placement is expected to close on or about July 5, 2012, subject to customary closing conditions.

Palatin intends to use the proceeds from this offering for general corporate purposes and working capital, including its clinical trial program with bremelanotide for female sexual dysfunction, preclinical and clinical development of its melanocortin receptor-1 peptide program, preclinical and clinical development of its PL-3994 program and preclinical and clinical development of other portfolio products.

Both Series A and Series B warrants are exercisable at an initial exercise price of $0.01 per share.  The Series A warrants are exercisable immediately upon issuance and expire on the tenth anniversary of the date of issuance.  The Series B warrants are also exercisable immediately upon issuance, but only if Palatin's stockholders increase the number of its authorized shares of common stock, and expire on the tenth anniversary of the date of the increase in the number of authorized shares.  Both the Series A warrants and the Series B warrants are subject to limitation on exercise if the holder and its affiliates would beneficially own more than 9.99% of the total number of Palatin's shares of common stock following such exercise.
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
9. Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on December 1st
10. Animal Biotechnology - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), ... technologies and products for advanced microarray diagnostics, today ... CFE  to its Management team. In his capacity ... its transition from a development stage to a ... advance the Company,s capital market strategy and to ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Crown Bioscience, ... company, has launched a new Life Science division specializing ... preclinical research. , The first products released include ... controls, and soon to be released in vivo grade ... continue to expand their life science portfolio with additional ...
(Date:3/3/2015)... Milpitas, Calif. (PRWEB) March 03, 2015 ... risk management excellence were honored by the Global ... annual event which took place on Wednesday, February 25th, ... , The GSCRC was formed to bring together supply ... thought leaders to advance the professional discipline through opportunities ...
(Date:3/3/2015)... PARSIPPANY, N.J. , March 3, 2015  Thingee ... industry, will be delivering a presentation entitled, "Technology Adoption: ... Conference, Thriving through Innovations and Technology ,  in ... from March 11 to 13, 2015. Audiences looking to ... more effectively will want to be in the audience ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Crown Bioscience Launches Life Science Product Catalog 2Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4Thingee to present at 11th Annual Synergistix Users Conference 2
... Spherix Incorporated,(Nasdaq: SPEX ) reported that ... Nasdaq advising the Company that, because of the ... enforcement of,the bid price and market value requirements ... period will be in effect from October 16,2008 ...
... Michigan,s stem,cell research initiative -- Proposal 2 -- ... reprehensible Tuskegee Experiments as a basis,for comparison to ... myths and,misinformation. Distortions about the nature and regulatory ... is important to set the facts straight., ...
... England, Oct. 23 BioWisdom Ltd (BioWisdom),the ... the,pharmaceutical industry, today announces the release of ... data are increasingly being used in competitive ... and business decisions.,OmniViz Visualization Software can turn ...
Cached Biology Technology:Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period 2Anti-Stem-Cell-Research Ad Ignores Facts 2Anti-Stem-Cell-Research Ad Ignores Facts 3
(Date:2/5/2015)... Calif. , Feb. 3, 2015 ... technology, demand from industries such as consumer electronics, ... market for surface mount technology (SMT) screen printers. ... to automatic control will push the adoption curve ... will remain steady as glue dispensers are indispensable ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a ... the recent success of the Wocket™ smart wallet at CES 2015 in ... was named as one of the "11 Hot Products at CES" in ... At CES So Far" by Newseveryday.com and "The top 10 gadgets from ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... cow disease-testing program is wholly inadequate and the ... testing further undercuts the safety of American beef, ... meat from cattle infected with bovine spongiform encephalopathy, ... a fatal human brain-wasting disorder. More than 160 ...
... NH&MRC, industry and state governments released today by the ... up to 275 new victims each day throughout Australia. ... Lifestyle Study (AusDiab) were presented today to the Federal ... provide the first definitive, clear picture of the rising ...
... proliferation of a broad range of lethal malignant glioma ... in the May issue of Cancer Cell, shed light ... to play a role in cancer progression. This study ... must display a broad reactivity to effectively attenuate the ...
Cached Biology News:Federal testing for mad cow disease a failure, law review editor says 2Federal testing for mad cow disease a failure, law review editor says 3Federal testing for mad cow disease a failure, law review editor says 4Diabetes hits 275 Australians each day as pandemic spreads 2Diabetes hits 275 Australians each day as pandemic spreads 3Unique dual target specificity of kinase inhibitor key for success against cancer 2
... chromatographically purified from egg white. The extinction coefficient ... is in 10 mM phosphate-buffered saline, ... 0.05% sodium azide and 50% glycerol. Avidin (from ... is purified by molecular sieving and ...
Request Info...
Request Info...
... ml CELLection Dynabeads (4.5 m) coated with ... antigen EpCAM and DNase Releasing Buffer. ... epithelial tumour cells directly from blood, bone ... be enriched from bone marrow. Enriched cells ...
Biology Products: